When added to chemotherapy for breast cancer treatment, Herceptin (trastuzaumab) has proven to improve survival rates, according to research conducted at he Mayo Clinic in Jacksonville. The study, published in the Journal of Clinical Oncology, surveyed data on over 4,000 women with breast cancer, one half got chemo, while the other half got chemo with one year of treatment with Herceptin.
Fiber based laxatives have been linked to a decreased risk of colon cancer, according to research conducted at the Fred Hutchinson Cancer Research Center in Seattle. The study, published in The American Journal of Gastroenterology, surveyed data on more than 75,000 adults aged 50 to 76. "I wouldn't necessarily jump the gun and say because of this study, people should stop taking stimulant . . ."
Those who smoke cigarettes and use chewing tobacco face a greater risk of infection with oral human papillomavirus type 16 (HPV16), according to research conducted at Johns Hopkins University. The study, published in JAMA, surveyed data on 6,887 adults (aged 18-59) who had been tested for HPV, reported tobacco use, and had given blood and urine samples for tobacco and nicotine testing.
Many people who are diagnosed with cancer also struggle with depression and anxiety, according to research conducted at the University of Leipzig. The study, published in the Journal of Clinical Oncology, based its findings on interviews with over 2,100 Germans (aged 18-75) with cancer. The team found that 32 percent of patients diagnosed with cancer wound up with a psychological disorder.
Black mothers who choose to not breastfeed may be at a higher risk of breast cancer than those who do, according to research conducted at Boston University's Slone Epidemiology Center. The study, published in the Journal of the National Cancer Institute, surveyed data on nearly 3,700 black breast cancer patients.
The extract of a wild berry native to North America may strengthen the effectiveness of a chemotherapy drug commonly used to treat pancreatic cancer, according to a new study. Research, published online in the Journal of Clinical Pathology, suggests that adding nutraceuticals to chemotherapy cycles may improve the effectiveness of conventional drugs, particularly in hard to treat cancers.